(4-043) The Efficacy and Safety of gp2013-rituximab: A Rituximab Biosimilar in a Tertiary Care Hospital in Lebanon

Monday, December 5, 2022

2:00 PM – 3:30 PM

Location: Bayside A, Level 1

Category: Descriptive Report
Topic: Oncology/Hematology

Co-Author(s): Rony Zeenny

Primary Author(s)

Jad El Tom, Pharm.D.
Pharmacy Resident PGY1
American University of Beirut Medical Center, Beyrouth, Lebanon